Abstract:Viral vectors have become very popular to overexpress or downregulate proteins of interest in different cell types. They conveniently allow the precise targeting of well-defined tissue areas, which is particularly useful in complex organs like the brain. In theory, each vector should have its own cell specificity that can be obtained by using different strategies (e.g., using a cell-specific promoter). For the moment, there is few vectors that have been developed to alternatively target, using the same capsid, neurons and astrocytes in the central nervous system. There is even fewer examples of adeno-associated viral vectors able to efficiently transduce cells both in vitro and in vivo. The development of viral vectors allowing the cell-specific downregulation of a protein in cultured cells of the central nervous system as well as in vivo within a large brain area would be highly desirable to address several important questions in neurobiology. Here we report that the use of the AAV2/DJ viral vector associated to an hybrid CMV/chicken β-actin promoter (CBA) or to a modified form of the glial fibrillary acidic protein promoter (G1B3) allows a specific transduction of neurons or astrocytes in more than half of the barrel field within the rat somatosensory cortex. Moreover, the use of the miR30E-shRNA technology led to an efficient downregulation of two proteins of interest related to metabolism both in vitro and in vivo. Our results demonstrate that it is possible to downregulate the expression of different protein isoforms in a cell-specific manner using a common serotype. It is proposed that such an approach could be extended to other cell types and used to target several proteins of interest within the same brain area.

Efficient Therapeutic Gene Expression in Cultured Rat Hippocampal Neurons Mediated by Human Foamy Virus Vectors: A Potential for the Treatment of Neurological Diseases

Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes.

Construction of HFV Vector-Mediated GAD Gene and Its Application

Gene Transfer into the Nervous System using Recombinant Herpes Virus Vectors

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Helper-Dependent Adenoviral Vector-Mediated Gene Transfer in Aged Rat Brain

Highly Branched Poly(β-Amino Ester) Delivery of Minicircle DNA for Transfection of Neurodegenerative Disease Related Cells

Development of Foamy Virus Vectors for Gene Therapy for Neurological Disorders and Other Diseases

Highly Efficient Retrograde Gene Transfer into Motor Neurons by a Lentiviral Vector Pseudotyped with Fusion Glycoprotein

A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury.

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5

A New Method of Gene Transfection into Cultured Hippocampal Neurons of Rats

Targeted Delivery of Large Fusion Protein into Hippocampal Neurons by Systemic Administration.

An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery

Development of Efficient AAV2/DJ-Based Viral Vectors to Selectively Downregulate the Expression of Neuronal or Astrocytic Target Proteins in the Rat Central Nervous System

Long Term Gene Therapy of Parkinson's Disease Using Immortalized Rat Glial Cell Line with Tyrosine Hydroxylase Gene.

Efficient Transduction of Feline Neural Progenitor Cells for Delivery of Glial Cell Line-Derived Neurotrophic Factor Using A Feline Immunodeficiency Virus-Based Lentiviral Construct

Gene delivery into primary cerebral cortical neurons by lentiviral vector.

Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types